USC.edu
Are You a Patient?

Jason Kane Russell

Postdoctoral Scholar - Research Associate

Image of Jason Kane Russell
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Publications

  • Facial feature removal in magnetic resonance imaging scans of adults with Down syndrome: A de-facing methodological study. Alzheimers Dement. 2026 Jul; 22(7):e71614.. View in PubMed
  • Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome. JAMA Neurol. 2026 Mar 01; 83(3):294-296.. View in PubMed
  • Decoding Alzheimer’s disease through down syndrome: insights from a genetically defined population. Curr Opin Neurol. 2026 Apr 01; 39(2):210-216.. View in PubMed
  • Relationship of cholinergic basal forebrain atrophy with the time course of Alzheimer’s disease pathology and cognitive decline in adults with Down syndrome: a longitudinal cohort study. Alzheimers Dement. 2026 01; 22(1):e71028.. View in PubMed
  • Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer’s disease: a single ascending-dose study in healthy participants. Alzheimers Res Ther. 2025 07 01; 17(1):144.. View in PubMed
  • Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer’s disease: A Single Ascending-Dose Study in Healthy Participants. Res Sq. 2025 Apr 04.. View in PubMed
  • Brain cholinergic terminal density utilizing [18F]-fluoroethoxybenzovesamicol PET in adults with Down’s syndrome: Relationship to amyloid PET and cognitive performance. Alzheimers Dement. 2025 04; 21(4):e70134.. View in PubMed
  • Resistance and resilience to Alzheimer’s disease in Down syndrome. Alzheimers Dement. 2025 04; 21(4):e70151.. View in PubMed
  • Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [18F]-fluoroethoxybenzovesamicol positron emission tomography imaging. Neurobiol Aging. 2025 04; 148:50-60.. View in PubMed
  • Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer’s Disease. Curr Top Behav Neurosci. 2025; 69:49-78.. View in PubMed

Similar People